Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable Finances

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Washington

About this trial

Quantify the impact of an online Virtual Community of Practice (VCoP) to increase pharmacist knowledge and accelerate provision of pre-exposure prophylaxis (PrEP) for HIV prevention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pharmacists or pharmacy staff working at pharmacy in U.S.

Pharmacy is not currently providing PrEP

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual Community of Practice

    Behavioral

    Healthcare communities of practice (CoPs) are becoming increasingly popular. CoPs unite individuals with common interests and provide opportunity to collaboratively learn and develop skills to improve professional practice, and reduce isolation. CoPs can play a role when educational needs cannot be satisfied by traditional methods. With advances in technology and the COVID-19 pandemic, virtual communities of practice (VCoPs) have spread across the globe. One of the primary benefits of online VCoPs is expanded potential for professional development and remote networking. VCoP members can use asynchronous communication to develop relationships and learn from peers who have experience with laws, policies, insurance companies and other healthcare institutions across the U.S. This education and peer support provided by VCoPs could be particularly beneficial for pharmacists in rural areas or in EHE jurisdictions without access to similar resources as academic or urban pharmacists.

  • Enhanced Standard of Care

    Behavioral

    A self-guided business and program planning. This arm will be sent a syllabus introducing them to the six-month business and program plan. Assignments will be delivered every other week, focusing on clinical, epidemiological, and business related educational tasks to be completed to prepare pharmacist to offer PrEP. The study team will be available for email assistance.

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Enhanced Standard of CareActive comparator 1 intervention
Group B: Virtual Community of Practice ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Time to first PrEP prescription

Time to first PrEP prescription by participating pharmacists as self-reported.

Time frame
for 2 years from participant enrollment.

Secondary outcomes

1

PrEP Clinics Started

Total number of PrEP Clinics started by participants

Time frame
within 2 years of participant enrollment
2

Total numbers of PrEP prescriptions initiated

Total numbers of PrEP prescriptions initiated by participants

Time frame
within 2 years of participant enrollment
3

characteristics of PrEP patients

characteristics of PrEP patients

Time frame
2 years post-enrollment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Washington

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: